Parasite with Cysts in Liver
Echinococcus granulosus (causing cystic echinococcosis/hydatid disease) is the most common parasite causing liver cysts, affecting 70% of infected individuals, and requires a multidisciplinary approach combining imaging, serology, and treatment tailored to cyst size, stage, and complications. 1
Causative Organism and Epidemiology
The primary parasite is Echinococcus granulosus sensu lato, which causes cystic echinococcosis (CE). A less common but more aggressive species is E. multilocularis, causing alveolar echinococcosis (AE) - these two must be distinguished from the outset as their management differs significantly 1.
Geographic distribution: In the UK, most cases occur in migrants from Eastern Europe, Middle East, and North Africa. The disease is endemic in these regions plus Central Asia 1.
Transmission: Ingestion of eggs from canine feces, sometimes via contaminated vegetables 1.
Incubation period: Months to years, making diagnosis often delayed 1.
Clinical Presentation
Most cases are asymptomatic and discovered incidentally on abdominal imaging 1. Cysts can grow to several liters in size.
When symptomatic, patients present with:
- Right upper quadrant pain and fever (from leaking or infected cysts)
- Hepatomegaly
- Obstructive jaundice
- Life-threatening complications: Rupture into peritoneal space causing anaphylaxis or secondary cyst formation 1
Critical pitfall: Eosinophilia is usually only present with leaking cysts; most asymptomatic cases have normal eosinophil counts 1.
Diagnostic Approach
Imaging (Primary Diagnostic Tool)
Ultrasound is the main diagnostic technique 1, with MRI providing superior characterization 2. The WHO classification system based on ultrasound appearance guides treatment decisions 1.
CT/MRI provides detailed information on:
- Cyst characteristics and stage
- Distribution in liver
- Anatomical relationships
- Presence of complications
Serology
Antibody detection against hydatid antigens, though not invariably positive 1. Serology complements but does not replace imaging.
Key Diagnostic Features
- Multi-site disease occurs in 20-40% of individuals 1
- Lungs are affected in 20% of cases
- Other sites (CNS, bone, eye, heart) in 10% 1
Treatment Algorithm
All cases should be managed through a specialist multidisciplinary team involving surgeons, radiologists, and infectious disease physicians 1. In the UK, specialist centers include Hospital for Tropical Diseases (UCLH London) and Liverpool 1.
Treatment Based on Cyst Characteristics:
For cysts <5 cm:
- Albendazole 400 mg twice daily alone 3
- Duration determined by cyst type
For simple liver cysts (WHO stage 1) ≥5 cm:
- PAIR (Puncture, Aspiration, Injection, Re-aspiration) plus drug therapy 3
- Albendazole 400 mg twice daily
- Praziquantel 20 mg/kg twice daily for 2 weeks pre- and post-procedure 3
For larger, extrahepatic, or multiple cysts:
- Surgical intervention indicated 3
- Perioperative albendazole and praziquantel as above
For late-stage cysts (WHO type 4 or 5):
- Careful observation with sequential ultrasound scans 3
Critical Management Considerations
Albendazole is preferable to mebendazole 1. Treatment duration depends on cyst type and whether curative resection was achieved.
Major risks: Anaphylaxis and cyst dissemination during surgical or percutaneous interventions - treatment must only be performed in specialist centers 3.
Alveolar Echinococcosis (E. multilocularis)
This is rare but more serious 3. Key differences:
- Small, interconnected cysts that infiltrate and metastasize
- No surrounding membrane makes surgery difficult
- Requires radical resection, not simple enucleation
- Long-term (often lifelong) albendazole required 3
- High recurrence rate
- Praziquantel has NO activity against AE 1
- Can progress rapidly in immunocompromised patients 1
- Liver transplantation may be needed for advanced disease 1
Staging is essential from the outset using WHO IWGE consensus guidelines to determine management strategy 1.
Other Parasites to Consider
While Echinococcus is the primary cause, other parasites can present with hepatic involvement:
- Fasciola hepatica (liver flukes) - presents with fever, hepatomegaly, and eosinophilia in acute phase; treated with triclabendazole 10 mg/kg single dose 3
- Clonorchis sinensis and Opisthorchis spp. (liver flukes) - chronic biliary obstruction, increased cholangiocarcinoma risk; treated with praziquantel 25 mg/kg three times daily for 2-3 days 1
Follow-up
Long-term follow-up is essential given the high recurrence risk and the disease's ability to remain clinically silent for years 4.